BRIEF-FDA Directs Takeda To Add Boxed Warning To Adzynma Drug Label

2

Sept 23 (Reuters) – FDA: * FDA: DIRECTED TAKEDA PHARMACEUTICALS TO ADD BOXED WARNING, ON DRUG LABEL, TO ADZYNMA'S PRESCRIBING INFORMATION Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)